INR 675.5
(0.39%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 17.37 Million | 157.59 Million | 75.47 Million | 116.85 Million | 3.21 Million | -67.67 Million |
Net Income | 160.62 Million | 133.88 Million | 87.73 Million | 10.81 Million | 77.75 Million | 146.94 Million |
Depreciation & Amortization | 49.69 Million | 46.78 Million | 33.05 Million | 24.68 Million | 25.2 Million | 43.23 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -243.44 Million | -17.89 Million | -43.9 Million | 96.48 Million | -67.29 Million | -231.62 Million |
Other non-cash items | 333.33 Million | -5.17 Million | -1.41 Million | -15.12 Million | -32.44 Million | -26.22 Million |
Investing Cash Flow | -121.22 Million | -189.79 Million | -65.55 Million | -24.11 Million | -27.93 Million | -52.04 Million |
Investments in PPE | -132.8 Million | -210.52 Million | -61.78 Million | -24.59 Million | -27.93 Million | -52.04 Million |
Acquisitions | 13.18 Million | 6.4 Million | - | 437 Thousand | 2.48 Million | - |
Investment purchases | -1.61 Million | 219.68 Million | -10 Million | - | - | - |
Sales/Maturities of investments | - | 5.16 Million | - | - | - | - |
Other Investing Activities | -132.8 Million | -210.52 Million | 6.23 Million | 39.99 Thousand | -2.48 Million | -52.04 Million |
Financing Cash Flow | 39.51 Million | 73.05 Million | -76.9 Million | -55.19 Million | 21.03 Million | 80.96 Million |
Debt repayment | -1.02 Million | -106.66 Million | -652 Thousand | -58.32 Million | -36.56 Million | -69.03 Million |
Dividends payments | - | -12.68 Million | -12.68 Million | - | -15.28 Million | -7.59 Million |
Common Stock Repurchased | - | - | - | - | - | -9.25 Million |
Common Stock Issuance | - | - | - | - | - | 23.59 Million |
Other Financing Activities | 38.48 Million | 192.4 Million | -63.57 Million | 3.12 Million | 72.89 Million | 143.25 Million |
Accounts receivables | -182.96 Million | -102.15 Million | 19.94 Million | 122.04 Million | -17.14 Million | 43.32 Million |
Accounts payables | - | - | 1000.00 | 20.54 Million | 1.00 | 1.00 |
Inventory | -484 Thousand | 598 Thousand | 1.88 Million | 2.73 Million | -994.85 Thousand | 19.68 Million |
Other working capital | -59.99 Million | 83.66 Million | -65.73 Million | -48.83 Million | -49.15 Million | -294.62 Million |
Cash at beginning of period | 106.61 Million | 65.75 Million | 132.74 Million | 95.2 Million | 98.88 Million | 137.63 Million |
Cash at end of period | 74.88 Million | 106.61 Million | 65.75 Million | 132.74 Million | 95.2 Million | 98.88 Million |
Capital Expenditure | -132.8 Million | -210.52 Million | -61.78 Million | -24.59 Million | -27.93 Million | -52.04 Million |
Effect of forex changes on cash | - | - | -1000.00 | - | - | - |
Net cash flow / Change in cash | -31.73 Million | 40.86 Million | -66.99 Million | 37.53 Million | -3.67 Million | -38.75 Million |
Free Cash Flow | -115.42 Million | -52.92 Million | 13.68 Million | 92.26 Million | -24.71 Million | -119.71 Million |
Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 160.62 Million | 49.49 Million | 36.05 Million | 14.7 Million | 133.88 Million | 40.92 Million |
Depreciation & Amortization | 49.69 Million | 12.31 Million | 12.6 Million | 12.39 Million | 46.78 Million | 13.64 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -243.44 Million | - | - | - | -17.89 Million | - |
Other non-cash items | 333.33 Million | -37.18 Million | -12.6 Million | -12.39 Million | -5.17 Million | -13.64 Million |
Investing Cash Flow | -121.22 Million | - | - | - | -189.79 Million | - |
Investments in PPE | -132.8 Million | - | - | - | -210.52 Million | - |
Acquisitions | 13.18 Million | - | - | - | 6.4 Million | - |
Investment purchases | -1.61 Million | - | - | - | 219.68 Million | - |
Sales/Maturities of investments | - | - | - | - | 5.16 Million | - |
Other Investing Activities | -132.8 Million | - | - | - | -210.52 Million | - |
Financing Cash Flow | 39.51 Million | - | - | - | 73.05 Million | - |
Debt repayment | -1.02 Million | - | - | - | -106.66 Million | - |
Dividends payments | - | - | - | - | -12.68 Million | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 38.48 Million | - | - | - | 192.4 Million | - |
Accounts receivables | -182.96 Million | - | - | - | -102.15 Million | - |
Accounts payables | - | - | - | - | - | - |
Inventory | -484 Thousand | - | - | - | 598 Thousand | - |
Other working capital | -59.99 Million | - | - | - | 83.66 Million | - |
Cash at beginning of period | 106.61 Million | 73.93 Million | 37.87 Million | 106.61 Million | 65.75 Million | 65.68 Million |
Cash at end of period | 74.88 Million | 98.55 Million | 73.93 Million | 14.7 Million | 106.61 Million | 106.61 Million |
Capital Expenditure | -132.8 Million | - | - | - | -210.52 Million | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -31.73 Million | 24.62 Million | 36.05 Million | -91.9 Million | 40.86 Million | 40.92 Million |
Free Cash Flow | -115.42 Million | 24.62 Million | 36.05 Million | 14.7 Million | -52.92 Million | 40.92 Million |
MPU
INFE
ADD
HESTERBIO
BAYERCROP
000550